Are you interested in knowing about the pharmaceutical companies in Serbia? Don’t worry you are fortunate to have come across this article.
The global pharmaceutical industry, valued at $500 billion, is one of the fastest-growing and most profitable industries in the world.
It continues to experience tremendous growth driven by innovation and advances at RandD. The competition for the development of new drugs and therapies has intensified as the companies have progressed.
To enable growth, many international pharmaceutical companies seek to expand through mergers and acquisitions or joint partnerships with smaller, more dynamic companies.
More recently, generics began to play a much more prominent role in the industry as more and more patents on “blockbuster” drugs expire.
Introduction to pharmaceutical companies in Serbia
The increasing pressure to supply third-world countries with inexpensive pharmaceuticals also makes the headlines for generic manufacturing. The generic trend has created tremendous business opportunities for companies to serve the base of the pyramid. Health care costs are a major problem worldwide. Along with the impact of aging populations, health costs are weighing on economies, particularly in Europe.
Governments are pressuring drug companies to provide affordable drugs. As a result, industry leaders continue to investigate ways to reduce manufacturing costs in order to contain rising health care spending. Serbian pharmaceutical companies have strategically positioned themselves to benefit from global trends in the industry.
Companies such as Hemofarm and Galenika, which have invested significant capital in development, expand the borders of medicine in the region.
Actavis, which is one of the leading generics manufacturers in Serbia, gives those who otherwise could not afford them access to cheap medicines. In addition, business incentives from Serbia, such as tax exemptions, profitable workers, and skilled workers, can help companies control costs. Investments in the emerging Serbian pharmaceutical sector are still in their infancy.
List of top Pharmaceutical companies in Serbia
In this section, you’ll find the list of some of the top pharmaceutical companies in Serbia among the thousands of companies that have been established in the country
Address: Maglajska, Beograd, Serbia
Phone: +381 11 4084509
Alpen Pharma d.o.o.
Address: Ulcinjska 13, Beograd, Serbia
Address: Bulevar Nemanjića 85a, Niš 18000, Serbia
Phone: +381 18 278877
Boehringer Ingelheim Serbia
Address: Milentija Popovića 5A, Beograd 11070, Serbia
Phone: +381 11 3115960
Address: Ilije Garašanina 23, Beograd, Serbia
Phone: +381 11 3232488
Address: Maksima Gorkog 42, Beograd 11210, Serbia
Phone: +381 69 4884888
Address: Borisavljevićeva 78, Beograd 11000, Serbia
Phone: +381 11 7700585
Located in: Galenika
Address: Belgrade, Serbia
Phone: +381 11 3071000
Goodwill Pharma d.o.o.
Address: Segedinski put 80, Subotica 24000, Serbia
Phone: +381 24 554498
Innventa Pharm d.o.o.
Address: Šumatovačka 36/9, Beograd 11000, Serbia
Phone: +381 11 4204466
KCR S.A. Representative Office
Address: Vladimira Popovića 38, Beograd 11070, Serbia
Phone: +381 11 7156953
Life Pharma d.o.o.
Address: Beogradskog bataljona 4, Beograd 11030, Serbia
Phone: +381 11 7357383
Novo Nordisk Pharma
Located in: Škoda “Čačak”
Address: Bulevar Milutina Milankovića 9b, Belgrade 11070, Serbia
Phone: +381 11 2222700
Address: 12C SUTJESKA ULICA 7, 11060, Beograd (Palilula), Grad Beograd, Serbia
Phone: +381 11 320555
Address: Kumanački put bb, Novi Bečej, Serbia
Phone: +381 23 775070
Address: Batajnički Drum 5a, 11000, Beograd 11000, Serbia
Phone: +381 11 3093900
Phoenix Pharma d.o.o.
Address: Obrenovački drum, Beograd, Serbia
Phone: +381 11 3538100
PSI CRO Belgrade SRB
Address: Trešnjinog cveta 11, Beograd 11070, Serbia
Phone: +381 11 2022500
Address: Reljina, Beograd, Serbia
Phone: +381 11 3626273
WÖRWAG Pharma GmbH & Co. KG
Address: Bulevar Zorana Đinđića 65, Beograd, Serbia
Phone: +381 11 6302920
Law For Serbia’s Pharmaceutical Companies
The manufacture and trade in drugs and other pharmaceutical products are regulated by the Drugs and Health Products Act (in force since August 1, 2004).
With this law, the Agency for Medicines and Health Products of Serbia was established to bring national regulations into line with EU standards.
Based on its mandate, the agency would be its counterpart to which does business in Serbia in many ways.
The following list shows some of the activities for which the agency is responsible:
- Issuing licenses for the trade-in drugs and medical devices
- Carrying out laboratory controls and quality tests of drugs and medical devices,
- Issuing licenses for the clinical research of drugs and medical devices and control of the conduct of clinical research
- Monitoring of side effects of drugs and medical devices
- Issuing of certifications for the implementation of the Good Medical Practices Policy (GMP) s in the clinical research of drugs and medical devices.
- Issuance of the necessary certifications for the export of medicinal products and medical devices in accordance with the recommendations of the WHO
- Authorization of the import of unregistered medicinal products and medical devices for the treatment of a patient or group of patients, such as importing drugs and medical devices for scientific research.
- Classification of drugs and medical devices,
- recording and processing of information on the sale and use of drugs and medical devices
Employment in Serbia’s Pharmaceutical Industry
The pharmaceutical sector workers in Serbia are highly qualified with specialized secondary and university degrees.
In addition to the high training profile of the workforce in the pharmaceutical sector, the annual number of new university graduates in the field of pharmaceutical sciences in Belgrade ensures the quality of its potential production in Serbia or a possible connection with a Serbian company.
Besides pharmacists, you can easily hire employees from other related fields of medicine. Medical universities in Serbia produced 977 graduates in 2004, while 376 students graduated from the School of Dental Medicine in the same year Like Ph.D. students, all Medical universities in Serbia produced 185 specialists, 195 Masters of Science, graduates, and 83 new doctors in 2003.
This human capital is available at very competitive prices of as salaries in Serbia are significantly lower than in the EU: the average gross monthly salary in the industry in 2004 was €472 (€ 326 net), which ensures high quality and cost-effective production.
Conclusion on the pharmaceutical companies in Serbia
The Serbian pharmaceutical market is one of the largest markets in the Central and Eastern Europe (CEE) region, the general Serbian pharmaceutical market is relatively underdeveloped, with regular drug shortages and somewhat long waiting times for patients.
While the market is small in absolute terms, relative per capita drug spending should improve over the long term.
We are open to hearing from you. Air your view in the comment box below.